WCP 2022 – 19th World Congress of Basic & Clinical Pharmacology – EMBRN – European Mast Cell and Basophil Research Network

Mast cell silencing: a novel therapeutic approach for urticarial and other mast cell-mediated diseases

Summary Chronic urticaria (CU) is a mast cell (MC)-dependent disease with limited therapeutic options. Current management strategies are directed at inhibiting IgE-mediated activation of MCs and

August 25, 2023

2B4 – A potential target in Staphylococcus aureus associated allergic inflammation

Summary Staphylococcus aureus (SA) and its exotoxins activate eosinophils (Eos) and mast cells (MCs) via CD48, a GPI-anchored receptor belonging to the Signaling Lymphocytes Activation Molecules (SLAM)

August 25, 2023

News

A memorial tribute to K. Frank Austen: the father of Mast Cell Biology

K. Frank Austen, a remarkable, dedicated mast cell scientist and mentor over almost seven decades, passed away on June 23rd at an age of 95 years.

June 27, 2023

European Mast Cell and
Basophil Research Network

WCP 2022 – 19th World Congress of Basic & Clinical Pharmacology

Looking for other posts?

Categories

Archives

Mast cell silencing: a novel therapeutic approach for urticarial and other mast cell-mediated diseases

2B4 – A potential target in Staphylococcus aureus associated allergic inflammation

A memorial tribute to K. Frank Austen: the father of Mast Cell Biology